Navigation Links
For Patients on Statins, Study Finds Filling 90 Day Supply Prescriptions through Mail Service Compared to Retail Pharmacy is Associated with Less Waste
Date:4/27/2011

ST. PAUL, Minn., April 27, 2011 /PRNewswire/ -- A new study shows 90-day statin drug claims filled through a mail service pharmacy are associated with less waste than a 90-day supply from a retail pharmacy. The findings of the study by Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, will be presented at the Academy of Managed Care Pharmacy's 23rd Annual Meeting and Showcase, taking place in Minneapolis, Minn. April 27-29.

Waste occurs when patients stop taking their medication, as a result of a dosage or drug switch, before the entire supply is used. Increasingly, patients with chronic conditions are moving to 90-day prescriptions, and previous studies have shown those receiving a 90-day prescription adhere better to their medications compared to those with a 30-day prescription.

"As an increasing number of patients move to 90-day prescriptions, this study shows we have an opportunity to reduce medication waste as a result of a dosage or drug switch if patients fill their prescription through mail service," said Patrick Gleason, PharmD, director of Clinical Outcomes Assessment, Prime.

For the study, researchers reviewed the claims of 51,261 Blue Cross and Blue Shield (BCBS) members who received statin prescriptions to identify those with overlapping claims. Researchers reviewed prescriptions filled from the second quarter of 2009 to the second quarter of 2010, via a retail pharmacy 30-day supply, a retail pharmacy 90-day supply and a mail service 90-day supply.

The results of the study show 3,996 of the 51,261 members (7.8 percent) with a statin claim had at least one day of waste, and the average days of waste was 24. Those receiving a 90-day supply via retail pharmacy had significantly higher waste (p<0.001) than those receiving their prescription through 30-day retail supply or 90-day mail service. Among those who received their medication through 90-day retail supply, those who were unable to use t
'/>"/>

SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. Many Heart Attack Patients Dont Get Best Emergency Treatment
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
11. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... July 25, 2014 GrowBLOX Sciences, Inc. (OTCQB: GBLX) ... of Understanding ("MOU") with LaurelCo, LLC, an Illinois ... of both cultivation and dispensary medical marijuana licenses in the ... MOU, GBLX will acquire a 20% equity interest in LaurelCo, ... TM growing chambers, as well as all technology related ...
(Date:7/25/2014)... HOUSTON , July 25, 2014  Solanbridge Group ... has acquired the majority interest in Buzznbrewz.com and the ... been replaced with a fully executed Purchase Agreement. ... Solanbridge, stated "We are proud to have Mr. ... has decades of experience in the private sector and ...
(Date:7/25/2014)... -- IDEXX Laboratories, Inc. (NASDAQ: IDXX ) today ... increased 11% versus the prior year period to $390 ... quarter of 2014 versus the prior year period was ... 2 . Earnings per diluted share ("EPS") for the ... prior year period to $1.10."In the second quarter, we ...
Breaking Medicine Technology:GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 3Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com 2IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29IDEXX Laboratories Announces Second Quarter Results 30IDEXX Laboratories Announces Second Quarter Results 31IDEXX Laboratories Announces Second Quarter Results 32IDEXX Laboratories Announces Second Quarter Results 33
... Technology Applicable for the Detection of a Host of Amyloid Neurological ... ... Parkinson Disease, ROCKVILLE, Md., Aug. 29 Adlyfe, a ... announced today the publication of a study, "Detection of,misfolded prion protein ...
... 28 Gilbert Hospital is,the first hospital in ... in,extracorporeal shockwave lithotripsy in the fight against painful ... waves in a,non-invasive procedure to break down kidney ... System has been added to Gilbert,Hospital,s arsenal of ...
Cached Medicine Technology:Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion 2Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion 3
(Date:7/25/2014)... older adults on five continents found that nearly 1 ... simple test that measures how fast people walk and ... for pre-dementia were twice as likely as others to ... scientists at Albert Einstein College of Medicine ... was published online on July 16, 2014 in ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Hastings and ... offering discount attorney’s fees with regard to personal injury ... provide a wide range of legal services for those ... negligence of another individual or corporation. Free initial consultation ... the validity of a potential personal injury claim ...
(Date:7/25/2014)... 2014 As thousands of transvaginal mesh ... Bernstein Liebhard LLP notes that the Food & Drug ... advocacy group, Public Citizen, to order a global recall ... May 1, 2014, and released to the public last ... a ban on the marketing of all surgical mesh ...
(Date:7/25/2014)... FRIDAY, July 25, 2014 (HealthDay News) -- Babies seem ... suggests. By the time women are 34 weeks ... of their mother,s voice reciting a familiar nursery rhyme, ... predominant source of sensory stimulation in the developing fetus," ... University of Florida,s College of Nursing, said in a ...
(Date:7/25/2014)... vulnerable neurons and reduce motor deficits in a ... University School of Medicine have shown. , The ... Parkinson,s Disease . , The findings demonstrate that ... at sufficient levels and have beneficial effects when ... Previous studies of XPro1595 in animals tested more ...
Breaking Medicine News(10 mins):Health News:Slow walking speed and memory complaints can predict dementia 2Health News:Slow walking speed and memory complaints can predict dementia 3Health News:Slow walking speed and memory complaints can predict dementia 4Health News:Hastings and Hastings Announces Complimentary Consultation Services 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 3Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 4Health News:Rhymes Reveal Evidence of Learning in the Womb 2Health News:Anti-inflammatory drug can prevent neuron loss in Parkinson's model 2
... Children exposed to chlorpyrifos-an insecticide, while in their mother’s ... by three years of age and also have a// ... in a peer-reviewed study conducted by Academy of Pediatrics. ... use in 2001, is still widely applied to agricultural ...
... Britain's heart experts are hoping to exploit the passion for ... people from the community not to delay calling// emergency help ... Asians in Britain have a 40-50 per cent higher death ... Asians are known to be reluctant to seek emergency help ...
... Meet organized by the city board of health on 5th ... use of Trans fat in the commercially prepared foods such ... Frieden, the health commissioner said, 'We hope that the board ... into consideration the concerns raised by 24,000 restaurateurs in New ...
... about chicken, which finds itself in the news, for all ... be hounded incessantly by germs. ,When Consumer reports ... 83% of the chickens were infected with either the campylobacter ... trigger diarrhea, cramping, nausea, fever, and vomiting, and can be ...
... A new study finds that the anti-craving drug, Naltrexone ... women who are trying to quit smoking appear //to ... individualized medicine, scientists are focusing on gender differences in ... Andrea King and her colleagues of the University of ...
... gained new ground to prove that your moms' advice, to eat ... best for you! If you chew your food well and take ... feeling better, says a new study. , Kathleen ... of this study. She compared the intake of calories of two ...
Cached Medicine News:Health News:Chlorpyrifos Affects Mental Development of Foetus 2Health News:British Heart Experts Use Cricket To Target South Asians 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: